聪哥
Lv71
3880 积分
2020-11-25 加入
-
IRAK4 inhibition dampens pathogenic processes driving inflammatory skin diseases
1小时前
待确认
-
Long-term outcomes of IgA nephropathy in China
4小时前
已完结
-
Papules, Plaques, and Nodules in an Immunocompromised Patient
17天前
已完结
-
Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21
17天前
已完结
-
Efficacy and safety of ustekinumab in Chinese patients with moderate to severe plaque-type psoriasis: results from a phase 3 clinical trial (LOTUS)
1个月前
已完结
-
Efficacy and safety of apremilast in subjects with moderate to severe plaque psoriasis: results from a phase II, multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group, dose‐comparison study
1个月前
已完结
-
Efficacy, tolerability, and pharmacodynamics of apremilast in recalcitrant plaque psoriasis: a phase II open-label study
1个月前
已完结
-
Oral Iptacopan Monotherapy in Paroxysmal Nocturnal Hemoglobinuria
1个月前
已完结
-
Iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria: a 2-cohort open-label proof-of-concept study
1个月前
已完结
-
Addition of iptacopan, an oral factor B inhibitor, to eculizumab in patients with paroxysmal nocturnal haemoglobinuria and active haemolysis: an open-label, single-arm, phase 2, proof-of-concept trial
1个月前
已完结